Activated Protein C Resistance
Activated protein C resistance in Behcet’s disease
5
Acquired activated protein C resistance and thrombosis in multiple myeloma patients
6
Effects of (pre-) analytical variables on activated protein C resistance determined via a thrombin generation-based assay
10
Increased Prevalence of Activated Protein C Resistance During Pregnancy may Implicate Venous Thrombo Embolic Disorders as a Common Cause of Maternal Mortality in Nigeria
7
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
5
The Leiden Thrombophilia Study (LETS)
5
The Role of Protein C, Protein S, and Resistance to Activated Protein C in Legg-Perthes Disease
8
Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487
17
Anticoagulant synergism of heparin and activated protein C in vitro Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C
10
Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis
5
Platelet factor 4 impairs the anticoagulant activity of activated protein C
7
Physiological anticoagulation Resistance to activated protein C and venous thromboembolism
6
Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans
5
Activated protein C in septic shock: a propensity matched analysis
7
Activated protein C modulates the proinflammatory activity of dendritic cells
9
The effect of activated protein C on experimental acute necrotizing pancreatitis
7
Generation of fibrinolytic activity by infusion of activated protein C into dogs
9
New players in the sepsis protective activated protein C pathway
5
On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies
9
The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b
11